Search

Author/Creator Melegari, E.

1. Impact of Ki67 and progesterone receptor on PFS with cyclin-dependent kinase 4/6 inhibitors in HER2-negative advanced breast cancer: A real world mono-institutional experience. (October 2020)

Authors:
Palleschi, M.; Barzotti, E.; Melegari, E.; Manunta, S.; Mannozzi, F.; Vagheggini, A.; Maltoni, R.; Fedeli, A.; Sarti, S.; Cecconetto, L.; Possanzini, P.; Ravaioli, S.; Tumedei, M.M.; Amadori, D.; Bravaccini, S.; Rocca, A.
Journal:
European journal of cancer
Issue:
Volume 138(2020)Supplement 1
Page Start:
S66
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Metronomic chemotherapy for advanced breast cancer patients in the real world practice: Final results of the VICTOR-6 study. (December 2019)

Authors:
Cazzaniga, M.E.; Pinotti, G.; Montagna, E.; Amoroso, D.; Berardi, R.; Butera, A.; Cagossi, K.; Cavanna, L.; Ciccarese, M.; Cinieri, S.; Cretella, E.; De Conciliis, E.; Febbraro, A.; Ferraù, F.; Ferzi, A.; Fiorentini, G.; Fontana, A.; Gambaro, A.R.; Garrone, O.; Gebbia, V.
Journal:
Breast
Issue:
Volume 48(2019)
Page Start:
7
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search